LYGENESIS INC.

Profile

Company Names

LYGENESIS INC.

Addresses

1710 MURRAY AVE, SUITE 200, PITTSBURGH, PA 15217

2730 SIDNEY STREET, PITTSBURGH, PA 15203

1543 SHADY AVENUE, PITTSBURGH, PA 15217

Phone Numbers

412-449-9983

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$25,825,226.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-10-05 
$17,764,699.00 
$20,000,000.00 
$2,235,301.00 
Equity 
3
2020-12-14 
$1,850,000.00 
$20,546,000.00 
$18,696,000.00 
Equity, Debt 
2
2019-10-18 
$4,000,000.00 
$4,000,000.00 
$0.00 
Equity, Debt 
1
2018-05-09 
$2,210,527.00 
$3,210,527.00 
$1,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GREGORY 
 
BAILEY 
DIRECTOR
REGISTERPATIENT.COM, INC.   |  INGAGEPATIENT, INC.   |  SALVARX GROUP PLC   |  DENIM LABS, INC.   |  JUVENESCENCE LTD   |  LYGENESIS INC.   |  AGEX THERAPEUTICS, INC.   |  DENIM SOFTWARE, INC.   |  SABR HOLDINGS LTD   |  CHELSEA AVONDALE GROUP LTD.   |  PORTAGE BIOTECH INC.   |  ALPHATON CAPITAL CORP
JUSTIN 
 
BRIGGS 
DIRECTOR
LYGENESIS INC.   |  MORPHOCEUTICALS, INC.
STEVE 
 
FELSTEAD 
DIRECTOR
LYGENESIS INC.
PAULO 
 
FONTES 
EXECUTIVE OFFICER, PROMOTER
LYGENESIS INC.
MICHAEL 
 
HUFFORD 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
E-NICOTINE TECHNOLOGY, INC.   |  LYGENESIS INC.
ERIC 
 
LAGASSE 
EXECUTIVE OFFICER, DIRECTOR
LYGENESIS INC.
ERIC 
 
LEGASSE 
EXECUTIVE OFFICER, PROMOTER
LYGENESIS INC.
JAMES 
 
MELLON 
DIRECTOR
POLO RESOURCES LTD   |  BRAZILIAN GOLD CORP   |  SALVARX GROUP PLC   |  JUVENESCENCE LTD   |  INSILICO MEDICINE, INC.   |  INSILICO MEDICINE CAYMAN TOPCO   |  LYGENESIS INC.   |  SABR HOLDINGS LTD   |  CHELSEA AVONDALE GROUP LTD.   |  PORTAGE BIOTECH INC.   |  NEW AGRARIAN CO LTD   |  GOOD DOG FOOD LTD   |  LIBERATION LABS HOLDINGS INC.   |  ALPHATON CAPITAL CORP   |  LIBERATION BIOINDUSTRIES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-10-11
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-05 
2023-10-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-05 
2020-12-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2020-12-14 
2019-10-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2019-10-18 
2018-05-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#